• First Immunotherapy Approved for Patients with Small Cell Lung Cancer

    Comments by David M. Waterhouse, MD, MPH, co-director of research with OHC. Article by Arthur N. Brodsky, PhD, Cancer Research Institute, Blogs 2 comments
    September 4, 2018

    immunotherapy small cell lung cancer

    On August 17, 2018 the FDA approved the first immunotherapy – the checkpoint inhibitor nivolumab (Opdivo) – for patients with small cell lung cancer (SCLC). This approval provides an important treatment option for patients with metastatic SCLC who have progressed after other treatments. The approval was based on the CheckMate-032 phase I/II clinical trial. “This […]

    Read More
  • OHC doctor teaches ER residents how to respond to cancer issues

    OHC, Blogs 0 comments
    August 29, 2018

    car t-cell therapy acute leukemia

    Today, OHC’s James H. Essell, MD, a leading authority on blood and marrow transplant and a national expert leading the CAR T-cell therapy program for The US Oncology Network, was invited to spend time with emergency medicine residents at the University of Cincinnati teaching them about the newest advancements in cancer care. When the residents […]

    Read More
  • Are there other signs of breast cancer besides a lump?

    Comments from Cynthia Chua, MD, OHC medical oncologist. Original article by Rachel Nall, RN, BSN, CCRN, Medical News Today., Blogs 0 comments
    August 24, 2018

    breast cancer signs besides lump

    A lump in the breast is just one of the possible signs of breast cancer in men or women. Sometimes there may be signs and symptoms of breast cancer without a noticeable lump in the breast. These symptoms may not be caused by cancer, but they might be. “Anytime someone notices a change in their […]

    Read More
  • Third Annual Cancer Chopped Champions Brings “Chefs” Together for Fun, Laughter and Cancer Education

    OHC, Blogs 0 comments
    August 21, 2018

    cancer chopped champions contestants

    Each year OHC (Oncology Hematology Care) and Cancer Support Community (CSC) bring together four “chefs” for fun, laughter and education as they battle their way to become the new Cancer Chopped Champion! This year marks the third annual Cancer Chopped Champions, to be held on Wednesday, September 19 from 6:30 – 7:30pm at the Edwin […]

    Read More
  • Could immunotherapy drug eliminate the recurrence of kidney cancer?

    David M. Waterhouse, MD, MPH, Co-director of Research at OHC, Blogs 0 comments
    August 15, 2018

    keytruda kidney cancer

    The average age of people diagnosed with cancer of the kidneys (renal cell carcinoma) is 64. Once diagnosed, if caught early, the five-year survival rate is 81%. But, if the cancer is caught at a later stage, survival rates plummet to less than 10%. In this day and age, 64 is very young. Many of […]

    Read More
  • Research Shows Potential New Strategy Against Thyroid Cancer

    Science Daily with additional comments from Robert B. Barriger, MD, radiation oncologist with OHC, Blogs 0 comments
    August 14, 2018

    thyroid cancer and SBRT

    Anaplastic thyroid cancer is one of the least common but most aggressive forms of thyroid cancer. Add to that, it’s resistance to cancer treatments. Patients diagnosed with the disease have an average lifespan of about five months after diagnosis. The standard treatment for the condition includes seven weeks of radiation, often with chemotherapy. Now a […]

    Read More
  • Lynch Syndrome: Is it a generational thing?

    Mark E. Johns, MD, a medical oncologist/hematologist with OHC who specializes in colon cancer, Blogs 0 comments
    August 6, 2018

    lynch syndrome

    Michele’s sister was diagnosed with colon cancer at age 33. Because her sister was so young, Michele’s doctor suggested she have a colonoscopy. The surgeon removed three pre-malignant tumors. Michele considers her sister and her doctors responsible for saving her life. Later, both sisters, as well as other family members, would receive genetic testing results […]

    Read More